Spinal Kinetics raises $5.3M to treat degenerative spine diseases

Spinal Kinetics, maker of artificial disks used to treat spine injuries and degenerative diseases, has brought in $5.3 million of an anticipated $9.5 million round of debt, rights and securities, according to a filing with the SEC. The Sunnyvale, Calif. company did not list investors in this round, but has been previously backed by the Ascent Group, BA Venture Partners, De Novo Ventures, HLM Venture Partners, International Life Sciences Fund, Ivy Capital Partners, Lumira Capital and Scale Venture Partners.

Next Story:
Previous Story:

About the Author,

Camille was the lead writer for GreenBeat until August 2010. To reach VentureBeat's current writers, email tips@venturebeat.com.

blog comments powered by Disqus